Organization
Hospital of Xinjiang Production and Construction Corps
1 abstract
Abstract
ACE-Breast-02: A pivotal phase II/III trial of ARX788, a novel anti-HER2 antibody-drug conjugate (ADC), versus lapatinib plus capecitabine for HER2+ advanced breast cancer (ABC).Org: Hospital of Xinjiang Production and Construction Corps,